{"id":7674,"date":"2018-12-21T12:13:12","date_gmt":"2018-12-21T11:13:12","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/von-martinsried-nach-paris-und-boston\/"},"modified":"2020-07-03T09:35:21","modified_gmt":"2020-07-03T07:35:21","slug":"von-martinsried-nach-paris-und-boston","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/","title":{"rendered":"From Martinsried to Paris and Boston"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

From Martinsried to Paris and Boston<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]SIRION Biotech expands after achieving milestone payment[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]December 2018[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=”7669″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 SIRION Biotech GmbH[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription”]Dieter Lingelbach and Dr. Christian Thirion, Managing Directors, SIRION Biotech GmbH (v.l.n.r.)[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]SIRION will use the funds recently received from licensees for further expansion abroad, for new technical developments and for the establishment of additional competences from the outside. The company is represented in Paris since September 2019, in order to serve the rapidly growing gene therapy market in France. Coming January, Boston, one of the biggest global hotspots for gene and cell therapies, will be added as a location.
\nSIRION is active in gene therapy and immuno-oncology and is dedicated to highly complex vectors or “gene ferries” with which a genetic “charge” is brought into a patient\u2019s cells, exploiting the same mechanisms, that are originally observed in viral infections. Almost exactly ten years after its foundation, the first patient was treated with SIRION technology in a clinical phase III in December 2016. The company with its approximately 30 employees received a first milestone payment in the single-digit million range. Based on promising patient data, the clinical development partner in the USA expects an approval in Europe in 2019.
\nA second clinical program entered Phase I in May 2018, an important milestone for SIRION. License agreements have already been concluded with four other clinical development partners. The first patients and test persons will be treated shortly. Two to three additional development and licensing collaborations are expected to be completed by the end of 2018.[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

SIRION will use the funds recently received from licensees for further expansion abroad,<\/span> for new technical developments and for the establishment of additional<\/span><\/span><\/p>\n","protected":false},"author":1,"featured_media":7667,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[286],"tags":[],"class_list":["post-7674","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-izb-news"],"yoast_head":"\nFrom Martinsried to Paris and Boston - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From Martinsried to Paris and Boston\" \/>\n<meta property=\"og:description\" content=\"SIRION will use the funds recently received from licensees for further expansion abroad, for new technical developments and for the establishment of additional competences from the outside. The company is represented in Paris since September 2019, in order to serve the rapidly growing gene therapy market in France. Coming January, Boston, one of the biggest global hotspots for gene and cell therapies, will be added as a location.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-21T11:13:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-03T07:35:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"341\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"p534396\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"p534396\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/\"},\"author\":{\"name\":\"p534396\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\"},\"headline\":\"From Martinsried to Paris and Boston\",\"datePublished\":\"2018-12-21T11:13:12+00:00\",\"dateModified\":\"2020-07-03T07:35:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/\"},\"wordCount\":394,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-5.jpg\",\"articleSection\":[\"IZB News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/\",\"name\":\"From Martinsried to Paris and Boston - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-5.jpg\",\"datePublished\":\"2018-12-21T11:13:12+00:00\",\"dateModified\":\"2020-07-03T07:35:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-5.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/00-Beitragsbild-5.jpg\",\"width\":400,\"height\":341},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/von-martinsried-nach-paris-und-boston\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IZB News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/izb-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"From Martinsried to Paris and Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/12499d818c4e3f59388b94103f0a527e\",\"name\":\"p534396\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"From Martinsried to Paris and Boston - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/","og_locale":"en_US","og_type":"article","og_title":"From Martinsried to Paris and Boston","og_description":"SIRION will use the funds recently received from licensees for further expansion abroad, for new technical developments and for the establishment of additional competences from the outside. The company is represented in Paris since September 2019, in order to serve the rapidly growing gene therapy market in France. Coming January, Boston, one of the biggest global hotspots for gene and cell therapies, will be added as a location.","og_url":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_published_time":"2018-12-21T11:13:12+00:00","article_modified_time":"2020-07-03T07:35:21+00:00","og_image":[{"width":400,"height":341,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg","type":"image\/jpeg"}],"author":"p534396","twitter_card":"summary_large_image","twitter_misc":{"Written by":"p534396","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#article","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/"},"author":{"name":"p534396","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e"},"headline":"From Martinsried to Paris and Boston","datePublished":"2018-12-21T11:13:12+00:00","dateModified":"2020-07-03T07:35:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/"},"wordCount":394,"commentCount":0,"publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg","articleSection":["IZB News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/","url":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/","name":"From Martinsried to Paris and Boston - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg","datePublished":"2018-12-21T11:13:12+00:00","dateModified":"2020-07-03T07:35:21+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/04\/00-Beitragsbild-5.jpg","width":400,"height":341},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/von-martinsried-nach-paris-und-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"IZB News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/izb-news\/"},{"@type":"ListItem","position":4,"name":"From Martinsried to Paris and Boston"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/12499d818c4e3f59388b94103f0a527e","name":"p534396"}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/comments?post=7674"}],"version-history":[{"count":10,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7674\/revisions"}],"predecessor-version":[{"id":11638,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/7674\/revisions\/11638"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/7667"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=7674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/categories?post=7674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/tags?post=7674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}